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The prevalence of opioid misuse and ad-diction is rapidly increasing.  In 2017, a record-breaking 72,000 people died from 
opioid overdoses (National Institute of Drug Abuse, 
2018a). Massachusetts is one of the top states in the 
nation for opioid-related overdose deaths.  In 2016, 
there were 29.7 opioid-related deaths per 100,000 
people, more than double the national average of 
13.3 deaths per 100,000 (National Institute of Drug 
Abuse, 2018b).  As of November, there were more 
than 1,200 confirmed opioid overdose deaths in 
2018 in the commonwealth (Massachusetts De-
partment of Public Health, 2018a).  Those who die 
from opioid overdoses in Massachusetts are pre-
dominately White and male.  Thus far in 2018, 73% 
of all confirmed opioid overdose deaths were male, 
and 81% were White (Massachusetts Department 
of Public Health, 2018a).  However, it is important 
to note that the percentage of Blacks who died from 
an opioid overdose increased by 4% in 2018 (Mas-
sachusetts Department of Public Health, 2018a).  
 Since 2013, there has been an overall in-
crease in Emergency Medical Services incidents 
that are opioid related (Massachusetts Department 
of Public Health, 2018b).  In 2017, there were 
22,215 opioid-related overdoses (fatal and non-fa-
tal) reported in Massachusetts (Massachusetts 
Department of Public Health, 2018b).  Compared 
to the general population, adults who survive a 
non-fatal opioid overdose are 24 times more likely 
to die in the year following the overdose (Olfson, 
Crystal, Wall, Wang, Liu, & Blanco, 2018).  Olfson 
et al. (2018) found that these deaths are attributed 
to a range of factors, including suicide, circulato-
ry diseases, and cancer.  However, the researchers 
found that the most common immediate cause of 
death within this population were substance-use as-
sociated diseases, including a subsequent overdose 
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(Olfson et al., 2018).  Previous research has found 
that rates of relapse with opioid-use disorder (OUD) 
were higher than with any other substance (Kadam, 
Sinha, Nimkar, Matcheswalla, & De Sousa, 2017; 
Tkacz, Severt, Cacciola, & Ruetsch, 2012). 
 One promising solution has been the use of 
peer supports in treatment.  Peer supports have been 
positively associated with treatment compliance in 
a variety of mental and physical health fields.  A 
meta-analysis of peer supports for addiction treat-
ment concluded that they were beneficial for pa-
tient outcomes (Bassuk, Hanson, Greene, Richard, 
& Laudet, 2016).  The Substance Abuse and Men-
tal Health Services Administration (SAMHSA) 
(2017a) and the U.S. Department of Veterans Af-
fairs (2011) found that peer supports were associ-
ated with reduced hospitalizations, reduced relapse 
rates, reduced substance use, and improved access 
to social supports. This article will discuss the his-
tory of policy and treatment of opioid-use disor-
der and illustrate why peer support is an emerging 
solution. 
A Historical Review of Policy
 Regulation is the primary response by the 
U.S. government when addressing drug addiction 
and illicit substances.  Until recently, treatment for 
substance abuse has been and still is punitive.  Reg-
ulatory measures have strongly focused on con-
trolling substances and the legal application of this 
treatment (Sacco, 2014). In 1914, the United States 
first federally regulated the prescribing of opioids 
with the Harrison Narcotic Act.  The Harrison Nar-
cotic Act did not prohibit the prescribing of opioids 
for addiction treatment by physicians in medical 
settings (Jaffe & O’Keeffe, 2003).   Officials desig-
nated to implement the act opposed the ambiguity 
and privilege of physicians to determine how they 
administered and treated in their medical practice 
(Jaffe & O’Keeffe, 2003).  This led to legal action 
against physicians prescribing opioids as a main-
tenance program for addiction (Jaffe & O’Keeffe, 
2003).    
 In 1919, the Supreme Court ruled against 
the use of opioid maintenance as a legitimate med-
ical practice.  The U.S. government’s first attempts 
at dealing with drug addiction were not to improve 
clinical services, research, and delivery methods. 
Rather, it targeted physicians and used threats of 
punishment by fines and imprisonment (McCarty, 
Priest, & Korthuis, 2018). The American Medical 
Association (AMA) strongly opposed prescribing 
opioids to addicts and in 1920, pushed to prose-
cute physicians who continued this practice.  The 
actions by the AMA were not strongly supported, 
and no significant changes occurred until after the 
end of 1964 (Jaffe & O’Keeffe, 2003).  
 The use of public health hospitals between 
1938 and 1974 were set up by authorization of 
Congress and were named U.S. public health 
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hospitals under the management of both the US 
Public Health Service and the Bureau of Prisons. 
It started off as a volunteer service for individu-
als who were convicted of federal drug crimes. 
Treatment was minimal but included management 
of withdrawal, a drug-free environment, psycho-
therapy, and education; in this atmosphere, success 
rates were low.  When these medical facilities were 
closed, they were repurposed and became federal 
correctional institutions (McCarty et al., 2018).   
 The 1960s saw a resurgence of addiction 
and included a heroin epidemic.  With the rise in 
use, positive American attitudes towards treatment 
of addiction evolved.  This development peeked, 
and political opinions ushered in the Narcotic Ad-
dict Rehabilitation Act (NARA) of 1966.  This Act 
was more than a response to public opinion. It le-
gitimized the use of oral methadone as a scientifi-
cally sound medical practice to treat addicts (Jaffe 
& O’Keeffe, 2003).  
 Additionally, the NARA started the use of 
community-based outpatient services.  This legis-
lation implemented the authorization of civil com-
mitments for two groups.  First, people convicted 
of federal drug offenses.  Second, to civilians and 
individuals who were not charged with a crime but 
were petitioned by the community or family mem-
bers to mandate a hospital commitment and super-
vision after treatment.  This attempt was plagued 
by slow implementation, the severe need for 
training, and a shortage of clinically trained profes-
sionals (McCarty et al., 2018). 
 Public and political response to substance 
misuse has been heavily influenced by racial pol-
itics. In 1971, President Nixon launched the “War 
on Drugs”.  Instead of supporting treatment options 
for individuals with substance-use disorders, drug 
use was criminalized, and mass incarceration en-
sued, increasing the country’s prison population 
350% (Pearl & Perez, 2018). The Anti-Drug Abuse 
Act of 1986 established mandatory minimum sen-
tences for possession and use of illegal substances 
(Cohen, 2015).  These sentences were far harsher 
on crack, typically used within inner-city commu-
nities of color, than on powder cocaine, a more ex-
pensive version of the drug, typically used within 
white suburban communities (Cohen, 2015).  The 
federal government’s response to opioid use within 
communities of color has historically focused on 
criminalization and punishment (Cohen, 2015). 
The current opioid epidemic has largely impacted 
White communities.  Thus, today’s focus on harm 
reduction versus criminalization is important to 
frame within the larger historical narrative of re-
sponses to substance misuse.  
Uses of Medication-Assisted Opioid Treatments 
 Research on the use of methadone for the 
treatment of OUD ensued. This prompted Con-
gress, and subsequently the Food and Drug 
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Administration (FDA) and the Drug Enforcement 
Administration (DEA), to implement regulations 
and oversights on the use of methadone in pro-
grams and clinics.  These programs multiplied and 
became widely used during the 1970s and 1980s. 
There were attempts by the FDA and the DEA to 
adhere strictly to the guidelines but with the expan-
sion and wide use, oversight became difficult (Jaffe 
& O’Keeffe, 2003; McCarty et al., 2018).   
 The period of increased regulation start-
ing in 1966 was followed by 30 years of effort to 
liberalize the FDA’s regulations.  Abstinence was 
the primary focus of all treatment during this time. 
The Controlled Substances Act of 1970 created a 
classification system for drugs based on their al-
leged likelihood of being abused.  These sched-
ules continue to impact the ability of physicians 
to prescribe medication-assisted opioid treatments 
today (Jaffe & O’Keeffe, 2003).  During this time, 
buprenorphine was developed and found to be an 
efficacious treatment option for opioid addiction. 
Due to its nature as a partial opioid agonist and its 
limited toxicity when ingested, legislation was de-
veloped and was submitted to Congress and signed 
into law.  This was known as the Drug Addiction 
Treatment Act of 2000 (Jaffe & O’Keeffe, 2003). 
Therapeutic communities emerged in the mid-
1950s and 1960s.  These settings were set up as 
long-term residential care.  These were prototypes 
of our current residential treatment system.  As 
they emerged, they had difficulties being accepted 
by the community because of the association with 
a long history of the criminalization of drug use 
and incarceration (McCarty et al., 2018).  These 
residential settings were also used for people with 
dysfunctional behavior and other deviant behav-
iors or thinking.  They were heavily criticized for 
being dehumanizing and confrontational.  Estimat-
ed dropout rates were between 70% and 75%, and 
outpatient-programs dropout rates were not signifi-
cantly different.  These institutionalized, communi-
ty-based residentials are now identified as an inef-
fective and inhumane way of treating persons with 
substance abuse or mental health issues (McCarty 
et al., 2018). 
The Current Legislative Landscape
 Improvement in treatment is imperative, 
and the policy is ever evolving in response to cur-
rent social needs.  In the last 20 years, the incidents 
of overdose deaths related to opioids have dramat-
ically increased.  This increase, often referred to as 
the “opioid epidemic”, is having significant social, 
political, and economic impacts on communities 
across the country, including within the Common-
wealth of Massachusetts.  The federal government 
has made many attempts in recent years to develop 
policies addressing this epidemic.  
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Federal  
 On a federal level, there is a long legislative 
history of attempted regulation and prohibition of 
certain substances.  Rates of drug overdoses slow-
ly increased under these policies (Coyne & Hall, 
2018).  In 1971, the death rate due to drug overdose 
was 1 in every 100,000 people. By 2014, it had ris-
en nearly 1500% to 14.7 overdose deaths in every 
100,000 people (Coyne & Hall, 2018; McCarty et 
al., 2018). According to Coyne and Hall (2018), 
prohibitive drug policies have increased rates of 
drug use and drug abuse.  Additionally, these pol-
icies have led to increases in use of more potent 
drugs, such as opioids. In 2014, 61% of drug-relat-
ed overdose deaths were due to opioids (Coyne & 
Hall, 2018).  
 Federal policies providing options for drug 
treatment are much more limited.  The use of opi-
oid-agonist treatment - the treatment of opioid 
dependence with medications, such as morphine, 
methadone, or buprenorphine - has been proven one 
of the most effective treatments for OUD (Nadel-
mann & LaSalle, 2017).  As previously mentioned, 
the Drug Treatment Act of 2000 expanded options 
for medication-assisted treatment of opioid addic-
tion, allowing physicians to prescribe schedule III, 
IV, and V drugs for opioid-agonist treatment (Jaffe 
& O’Keeffe, 2003). In 2002, the Federal Drug 
Administration (FDA) approved buprenorphine 
and buprenorphine/naloxone for use with opioid 
addiction (Jones, Viswanath, Peck, Kaye, Gill, & 
Simpoulos, 2015).  The 2006 Reauthorization Act 
increased the number of patients a physician could 
administer buprenorphine to from 30 to 100 (Jones, 
et al., 2016)  
 Opioid overdose deaths continued to rise 
despite increased treatment options.  In 2016, the 
number of drug overdose deaths related to opioids 
rose by 20% (Jones, et al., 2016).  Of the 42,000 
people who died from an opioid overdose in 2016, 
20,000 of them were due to use of fentanyl, 15,000 
were connected with heroin use, and the remainder 
were overdoses of prescription opioids (Jones et 
al., 2016).  
 Federal support for opioid-agonist treat-
ments grew under the Obama Administration. In 
2015, President Obama issued a Presidential Mem-
orandum directing states to analyze barriers to opi-
oid-agonist treatment and develop action plans to 
address these (Nadelmann & LaSalle, 2017).  Ma-
jor barriers remain, however, to patients enrolling in 
such treatment.  Methadone clinics face extremely 
restrictive policies, while access to buprenorphine 
is limited by many insurances, as well as policies 
on how many patients to which a single physician 
can prescribe (Nadelmann & LaSalle, 2017).  
 In 2016, the Comprehensive Addiction and 
Recovery Act (CARA) was signed into law.  This 
was the first major legislation in more than 40 years 
to comprehensively address drug addiction 
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(Community Anti-Drug Coalitions of America 
[CADCA], 2016).  This legislation changed a va-
riety of policies relating to treatment for OUD. 
CARA increased the number of patients a physi-
cian could administer buprenorphine to from 100 
to 275 (Substance Abuse & Mental Health Services 
Administration [SAMHSA], 2017b).  Additionally, 
it launched a variety of evidence-based practices 
for heroin and opioid addiction aimed to expand 
these treatment options nationally.  Some of the best 
practices recommended were medication-assisted 
treatment and expansion of diversion services to 
connect individuals to treatment rather than bring 
criminal prosecution (CADCA, 2016).  CARA also 
expanded partnerships with law enforcement agen-
cies and prisons to develop best practices for iden-
tifying and treating incarcerated individuals with 
substance use disorders (CADCA, 2016). 
 In October 2018, Congress passed the Sub-
stance Use Disorder Prevention that Promotes Opi-
oid Recovery and Treatment for Patients and Com-
munities (SUPPORT) Act.  The SUPPORT Act 
includes a variety of provisions impacting treat-
ment. It gave nurse practitioners and physicians 
prescribing authority and allowed for the develop-
ment of new addiction recovery centers, especially 
in communities which have been hit hardest by the 
opioid epidemic   (Garvin, 2018; National Council 
of State Boards of Nursing, 2018).  
 Peer support is not a new concept on a 
federal level.  In 2005, the Department of Veter-
ans Affairs (VA) instituted and funded positions for 
Peer Supports (PS) staff.  The VA recognized that 
the use of peer-support technicians is an effective 
research-based intervention that can significantly 
improve outcomes in treating substance abuse dis-
orders, including opioid addiction (Chinman, Shoi, 
& Cohen, 2010; Thomas, 2017; U.S. Department 
of Veterans Affairs, 2011). 
Massachusetts  
 Massachusetts has been one the states hard-
est hit by the opioid epidemic and thus has enacted 
a variety of policies in response.  In 2016, Massa-
chusetts passed an act relative to Substance Use, 
Treatment, Education, and Prevention (STEP). 
This legislation was developed collaboratively 
through conversations with medical professionals, 
policy makers, and community members (Mass. 
Gen. Laws, Chapter 52 & Section 32, 2016; Rud-
der, Tsao, & Jack, 2016).  The STEP Act included 
changes to opioid prescribing policies, education 
guidance for K-12 schools, and liability protections 
for civilians who administer naloxone to someone 
who has overdosed (Rudder et al., 2016).  
 Additionally, the STEP Act recognized 
the important role that hospital emergency rooms 
played in responding to survivors of non-fatal, opi-
oid overdoses.  When originally introduced, this 
legislation included an amendment calling for a 
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72-hour hold in which survivors of non-fatal opi-
oid overdoses could be held in the hospital against 
their will and forced to enter treatment involuntari-
ly (Beletsky, Parmet, & Sarpatwari, 2016).  The 72-
hour hold amendment was deeply contested and ul-
timately struck from the final legislation (Beletsky 
et al., 2016). In its place, the legislation required 
that a licensed mental health professional provide 
a substance abuse evaluation within 24 hours after 
a patient is admitted to the hospital for an opioid 
overdose (Mass. Gen. Laws, Chapter 52 & Section 
32, 2016).  
 In 2018, Massachusetts passed additional 
legislation to strengthen its response to the opioid 
crisis.  The Combating Addiction, Accessing Treat-
ment, Reducing Prescriptions, and Enhancing Pre-
vention (CARE) Act improved access to treatment, 
expanded school-based education programs, and 
broadened insurance coverage for alternative treat-
ments (Cyr, 2018).  The CARE Act also strength-
ened emergency rooms’ responses to opioid over-
dose. Under the CARE Act, individuals admitted 
for an opioid overdose must be provided with the 
option to begin treatment while in the hospital 
(Cyr, 2018).  This bill required all emergency de-
partments to have the capacity to begin voluntary 
opioid-agonist treatment if requested by the patient 
(Governor’s Press Office, 2018).  The CARE Act 
for the first time acknowledged the important role 
of peer supports in the treatment process.  The bill 
established a commission to recommend standards 
for developing a professional credential for peer 
supports as a way to standardize their role in the 
treatment and recovery process (Cyr, 2018).  
 Since the implementation of these policies, 
Massachusetts has seen a slight decline in rates of 
opioid-overdose deaths.  In 2016, the Common-
wealth reached a historic high of 31.6 overdose 
deaths per 100,000 people.  Preliminary 2017 num-
bers suggest those rates are down two percentage 
points to 29.6 overdoses per 100,000 people (Mas-
sachusetts Department of Public Health, 2018b). 
Massachusetts is a national leader in implementing 
effective legislative responses to the opioid epi-
demic (Sanger-Katz, 2018).  Continuing to invest 
in alternative treatments that further reduce rates of 
opioid overdose is an important legislative priority. 
Need for Further Legislative Action 
 As research has shown, OUD can be effec-
tively treated with opioid-agonist treatments that 
help relieve opioid cravings and improve function-
ing in everyday life (Canadian Agency for Drugs 
and Technologies in Health, 2016).  However, for 
these treatments to be effective, patients must com-
plete them.  Previous research has found that rates 
of relapse with opioid use is higher than any other 
substance (Kadam et al., 2017; Tkacz et al.,2012). 
Research on treatment compliance and overdoses 
has found that OUD patients who are 
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non-compliant with treatment are ten times more 
likely to relapse than those who were compliant 
(Tkacz et al., 2012).  Increased treatment compli-
ance leads to increased positive recovery outcomes 
for individuals with OUD.  Peer supports (PS) are 
a potentially promising response to support in-
creased treatment compliance (U.S. Department of 
Veterans Affairs, 2011; Wakeman, Jack, Magidson, 
& Regan, 2018).  
Peer Supports as a Solution 
 The Substance Abuse and Mental Health 
Services Administration (SAMHSA) (2018) de-
fined peer-support services as those administered 
by individuals with a history of addiction and suc-
cessful recovery.  Peer supports are found in both 
mental health and substance abuse fields. They 
may have a variety of job titles including recovery 
coaches, recovery support specialists, whole health 
and resiliency peer specialists, and certified peer 
specialists (National Association of State Mental 
Health Program Directors, 2014). In this article, 
the term peer supports will be used.  
 Literature on peer supports agrees that the 
ability to bring one’s lived experience to their work 
with a client is a unique and important component 
of the treatment and can help strengthen the ther-
apeutic alliance.  Additionally, research has found 
that peer supports can reduce incidents of relapse 
and increase treatment completion rates (Reif et al., 
2014; U.S. Department of Veterans Affairs, 2011). 
Peer supports are an evidence-based practice that 
the VA is implementing department-wide.  It is 
described as a fundamental building block that is 
oriented towards all recovery services within the 
framework of mental health (MH) services and 
multimodal treatment delivery.  The objective is to 
provide treatment modalities that meet the veter-
ans’ needs and improve the experience of treatment 
for all veterans who utilize the services delivered 
by Veterans Health Administration (U.S. Depart-
ment of Veterans Affairs, 2011).  
Supporting Treatment Compliance  
 Peer supports have been linked to increased 
treatment compliance for individuals with OUD. 
A study at Massachusetts General Hospital paired 
643 patients who were admitted to the hospital for 
a substance use-related incident with a peer sup-
port.  The research found that patients with a peer 
support were less likely to be readmitted to the hos-
pital and more likely to utilize outpatient treatment 
facilities (Wakeman et al., 2018).  Additionally, 
patients who voluntarily began buprenorphine for 
OUD were significantly more likely to be abstinent 
in the 6 months following their hospital admittance 
than patients who did not work with a peer sup-
ports (Wakeman et al., 2018).  This study offers 
promising insight on the role that peer supports 
can play in supporting treatment compliance for 
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patients with substance-use disorders, especially 
OUD.  Connecting OUD patients to a peer support 
may increase compliance with medication-assist-
ed treatment, reduce rates of relapse, and reduce 
opioid-related overdose deaths (Governor’s Press 
Office, 2018; SAMHSA, 2018; U.S. Department of 
Veteran’s Affairs, 2011).  
Concerns About Utilizing Peer Supports  
 Peer supports need a standard level of pro-
fessionalism and a clear scope of practice. There 
is concern that peer supports will replace clinical 
workers without clinical training.  For this reason, 
peer supports need to be identified as unique mem-
bers of a treatment team but not as a replacement 
for a clinician.  In addition, organizations imple-
menting peer supports need to develop policies that 
safeguard against peer supports being left to do less 
desirable or menial tasks (U.S. Department of Vet-
erans Affairs, 2011).  
 Concerns around dual relationships, or re-
lationships between peers who are concurrently 
participating in two or more roles, have emerged 
in response to the use of peer supports in addiction 
treatment.  For example, in the VA, one example of 
dual roles may be both being veteran consumers. 
This dual relationship may be benign.  Other dual 
relationships may be exploitive, for instance a sex-
ual relationship.  Care must be taken to inhibit dual 
relationships that violate the necessary boundaries 
between the peer support and consumer (U.S. 
Department of Veterans Affairs, 2011).  
 Finally, the potential of relapse is an ad-
ditional concern that has been voiced.  There is a 
need to ensure that identified peer supports have 
reached an assessed level in their process of recov-
ery that would allow them to assume the role of 
providing support (Myrick & Vecchio, 2016; U.S. 
Department of Veterans Affairs, 2011).  
Recommendations for Future Policy 
 As previously discussed, federal and state 
level policies have recently been passed to strength 
treatment options for individuals with OUD.  As 
these policies are merely months old, these authors 
cannot yet analyze the outcomes, impacts, and 
unintended consequences of this legislation.  As 
history has shown, policies have complex ramifi-
cations on political, social, and economic systems. 
It remains to be seen how recent legislation will 
impact the opioid epidemic.   
 Based on previously reviewed research, 
these authors have a series of recommendations for 
how to continue to strengthen legislative outcomes 
and improve treatment for OUD. Emergency de-
partments are at the frontlines of responding to 
opioid overdoses.  Massachusetts’ new legislative 
guidelines mandate that hospitals begin voluntary 
opioid-agonist treatment if requested by a patient 
before they leave the hospital (Governor’s Press 
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Office, 2018).  Under this new legislation, 
emergency departments must work with patients to 
connect them to appropriate outpatient resources in 
the community to continue their treatment upon re-
lease from the hospital. 
 Peer supports have a critical role to play in 
ensuring treatment compliance for these individ-
uals. These authors recommend that Massachu-
setts add legislation that requires peer supports to 
be assigned to any patient who accesses treatment 
through an emergency department following a 
non-fatal overdose.  A pilot program in two Rhode 
Island hospitals found increases in treatment com-
pletion when patients worked with a peer support 
following an emergency room visit (Samuels, Mel-
lo, Baird, & Yang, 2018).  This Rhode Island-based 
program- the Lifespan Opioid Overdose Preven-
tion (LOOP) program- partnered with a commu-
nity-based, peer recovery organization to provide 
additional addiction treatment support (Samuels et. 
al., 2018).   These authors recommend that Massa-
chusetts implement measures, like SAMHSA has 
recommended, and that the VA has implemented 
agency-wide, to build out peer supports as posi-
tions that are state-funded, trained, and supervised. 
The CARE Act, passed in August, developed a 
commission to make recommendations for stan-
dardizing the peer support specialist credentialing 
process (Governor’s Press Office, 2018).  A cre-
dentialing process will help to clarify the peer 
support role on a treatment team, develop a stan-
dard set of performance measures, define their 
scope of practice, develop a core curriculum to 
ensure consistent training, as well as standardize 
pay scales and compensation (National Association 
of State Mental Health Program Directors, 2014). 
These authors recommend that, in addition to the 
credentialing commission, Massachusetts establish 
a Peer Support Advisory Board, comprised of part-
ners from community agencies to make recommen-
dations and be involved in process improvements. 
This advisory board would be established as a per-
manent structure within Massachusetts’ peer sup-
port system to ensure that those on the frontline of 
treatment have a direct line to communicate and 
address process improvements.  This would create 
a concerted effort of governmental and communi-
ty agencies, working collaboratively to effectively 
implement peer supports to end the opioid epidem-
ic.  
Final Thoughts 
 The prevalence of opioid misuse and addic-
tion is rapidly increasing.  In 2017, a record breaking 
72,000 people died from opioid overdoses (Nation-
al U.S. Library of Medicine, 2018).  Studies have 
shown higher rates of relapse for individuals seek-
ing treatment for opioid addiction than other sub-
stance-use disorders.  Finding effective solutions 
to support the continued recovery and treatment 
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compliance of individuals struggling with opioid 
addiction is of the utmost importance (Kadam et 
al., 2017).  Mental health agencies are increasingly 
utilizing peer support specialists to support recov-
ery and treatment compliance for individuals with 
substance misuse.  Literature on peer-support spe-
cialists agree that the ability to bring one’s lived ex-
perience to their work with a client is a unique and 
important component of the treatment and can help 
strengthen the therapeutic alliance.  Additionally, 
research has found that peer-support specialists can 
reduce incidents of relapse and increase treatment 
completion rates (Reif, et al., 2014).  These authors 
argue that expanded use of peer support specialists 
amongst individuals suffering from opioid addic-
tion is an answer to continued treatment and recov-
ery. 
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